As a stealthy liver disease becomes more common, the search for treatments accelerates

people with NASH usually have no symptoms. It’s estimated that roughly 2 percent to 5 percent of adults in the United States have the disease, and that another 10 percent to 20 percent may have its milder cousin, non-alcoholic fatty liver disease, or NAFLD, according to the National Institute for Diabetes and Digestive and Kidney Diseases. NASH is expected to become the most frequent reason for liver transplants by 2020.

Showing 1 reaction

Please check your e-mail for a link to activate your account.

Click for our online community